Katharina Sahm1,2, Tobias Kessler3,4, Philipp Eisele5

  • 1Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany. k.sahm@dkfz.de.

Communications medicine
|December 19, 2023
PubMed
概括

多发性硬化症 (MS) 不影响质瘤风险. 患有并发性多发性硬化和IDH突变质瘤的患者面临更糟糕的预后和辐射后多发性硬化活动增加.